Summit Global Investments’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-7,871
Closed -$217K 542
2025
Q3
$217K Buy
+7,871
New +$242K 0.01% 446
2024
Q3
Sell
-6,049
Closed -$274K 591
2024
Q2
$274K Buy
6,049
+4
+0.1% +$184 0.02% 430
2024
Q1
$293K Buy
6,045
+312
+5% +$15.3K 0.02% 411
2023
Q4
$307K Buy
+5,733
New +$290K 0.02% 425
2022
Q4
Sell
-28,763
Closed -$1.61M 490
2022
Q3
$1.61M Buy
28,763
+7,856
+38% +$519K 0.15% 148
2022
Q2
$1.51M Buy
20,907
+5,556
+36% +$414K 0.13% 162
2022
Q1
$1.22M Sell
15,351
-3,200
-17% -$288K 0.09% 201
2021
Q4
$1.88M Buy
18,551
+300
+2% +$29.9K 0.12% 152
2021
Q3
$1.68M Sell
18,251
-1,000
-5% -$96.2K 0.13% 145
2021
Q2
$1.97M Buy
19,251
+12,300
+177% +$1.23M 0.12% 137
2021
Q1
$678K Buy
6,951
+3,251
+88% +$296K 0.04% 262
2020
Q4
$285K Buy
3,700
+200
+6% +$15.5K 0.03% 227
2020
Q3
$258K Buy
+3,500
New +$281K 0.03% 228

Other funds holding USNA

Summit Global Investments's USNA Position: Q4 2025 in Review

Summit Global Investments sold out of Usana Health Sciences (USNA) in Q4 2025, closing a stake of 7,871 shares — an estimated $217K sold.

Summit Global Investments first reported a position in USNA in Q3 2020 and held it in 13 quarters. The position peaked at $1.97M in Q2 2021. 121 funds tracked by Wall St. Rank hold USNA as of Q4 2025.

  • Summit Global Investments reported no remaining Usana Health Sciences position as of Q4 2025 after selling out during the quarter.
  • Summit Global Investments sold 7,871 Usana Health Sciences shares in Q4 2025, an estimated $217K.
  • Summit Global Investments first reported a position in Usana Health Sciences in Q3 2020 and held it in 13 quarters.
  • Summit Global Investments's Usana Health Sciences position peaked at $1.97M in Q2 2021.
  • 121 funds tracked by Wall St. Rank held Usana Health Sciences as of Q4 2025.

Based on Summit Global Investments's 13F filing for Q4 2025, filed 18 Feb 2026.